Status:

RECRUITING

Utility of ROTEM® for Risk Stratification of Post-Invasive Procedure Hemorrhage in Patients With Cirrhosis (CIR-ROTEM)

Lead Sponsor:

Instituto de Investigación Marqués de Valdecilla

Conditions:

Cirrhosis, Liver

Eligibility:

All Genders

18-65 years

Brief Summary

The assessment of post-procedural bleeding risk in cirrhosis remains a clinical challenge due to the lack of precise predictive tools and its high associated mortality. Although guidelines recommend a...

Eligibility Criteria

Inclusion

  • Age between 18 and 85 years.
  • Clinical, analytical, elastographic, histological, and/or imaging criteria consistent with the diagnosis of hepatic cirrhosis.
  • Undergoing a high-risk invasive procedure, either in an outpatient setting or during hospitalization.
  • Platelet count below 50,000/μL or INR greater than 1.5 with a platelet count below 100,000/μL.
  • Signature of informed consent.

Exclusion

  • Cirrhotic patients with acute-on-chronic liver failure (ACLF) as defined by EASL criteria, and patients admitted to Intensive Care Units. These patients are excluded because hemostatic alterations in ACLF and critically ill patients are different and more pronounced compared to those in outpatient or general medical ward settings.
  • Chronic kidney disease stage ≥3.
  • Presence and/or history of thromboembolic complications.
  • Presence of non-hepatic tumors.
  • Presence of any primary hematologic disease (including inherited coagulopathies or thrombophilia).
  • Recent surgery (\<8 weeks).
  • History of organ transplantation, including liver transplantation.
  • Pregnancy.
  • Use of anticoagulants, antiplatelet agents other than acetylsalicylic acid, and/or antifibrinolytic therapy.
  • Active disseminated intravascular coagulation.

Key Trial Info

Start Date :

March 1 2025

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

September 1 2028

Estimated Enrollment :

330 Patients enrolled

Trial Details

Trial ID

NCT06908785

Start Date

March 1 2025

End Date

September 1 2028

Last Update

April 3 2025

Active Locations (11)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 3 (11 locations)

1

Hospital universitario Marques de Valdecilla

Santander, Cantabria, Spain, 39008

2

Hospital General Universitario Dr. Balmis de Alicante

Alicante, Spain

3

Hospital Clinic Barcelona

Barcelona, Spain, 08036

4

. Hospital de la Santa Creu i Sant

Barcelona, Spain, 08041